Peripheral vascular commitment in diabetic patients: etiological factors and clinical manifestations

• Autor(a) principal: Moraes da Silva, Lorrany Fontenele
• Data de Publicação: 2021
• Outros Autores: Nogueira Ferreira, Adriana Gomes, Pereira, Ana Lúcia Fernandes, Pascoal, Lívia Maia, Neto, Marcelino Santos, Dutra, Richard Pereira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Saúde e Desenvolvimento Humano
• Texto Completo: https://revistas.unilasalle.edu.br/index.php/saude_desenvolvimento/article/view/6836
• topic: Diabetes Mellitus; Diabetic Foot; Peripheral Arterial Disease; Diabetic Neuropathies; Diabetic Angiopathies; Saúde coletiva; Diabetes mellitus; Pé diabético; Doença arterial periférica; Neuropatias Diabéticas; Angiopatias diabéticas

Introduction: The evaluation of peripheral perfusion is essential for the management of diabetic patients, in order to detect the risks of amputations and the evolution of wound healing.Objective: To identify the etiological factors and clinical manifestations that characterize peripheral vascular impairment in diabetic patients.Methodology: An integrative review was carried out in May 2019 using the following databases BDENF, CINAHL, LILACS, MEDLINE and PUBMED with the following descriptors in English and Portuguese: diabetic angiopathies, diabetes mellitus, diabetic foot. The sample consisted of 18 articles. The most frequent etiological factors were Peripheral Arterial Disease (PAD), duration of diabetes, peripheral neuropathy, advanced age and smoking. Regarding clinical manifestations, they presented a higher frequency of low Ankle-brachial Index (ITB), low Halluxbrachial Index (IHB), absence of peripheral pulses and delayed healing.Conclusion: PAD was more evident and considered the main cause of vascular involvement, it was found that ABI is not a safe technique to assess peripheral perfusion in diabetic patients and it must be performed in conjunction with IHB, the most reliable alternative. Therefore, it is essential for health professionals to track the etiological factors and clinical manifestations in order to provide targeted care to this at-risk population.